EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Mon, 23.12.2024
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, December 23rd, 2024
3rd Interim Report
In the period from December 16th up to and including December 20th, 2024, a total of 9,277 shares of Alzchem Group AG were acquired as part of the sha...
Alzchem Group AG
Disclosure
according to Article 5 of the EU Regulation 596/2014
and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Temporary Interruption of Share Repurchase Program
Alzchem Group AG temporarily interrupts its share repurchase program as published by announcement dated November 29, 2024 starting ...
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, December 16th, 2024
2nd Interim Report
In the period from December 9th up to and including December 13th, 2024, a total of 13.964 shares of Alzchem Group AG were acquired as part of the sh...
Alzchem Group AG: Private placement of Alzchem shares by LIVIA Corporate Development SE and HDI Vier CE GmbH successfully completed
Trostberg, December 11, 2024 – Alzchem Group AG has been informed by its shareholders, LIVIA Corporate Development SE und HDI Vier CE GmbH, that the announced private placement of 250,000 shares (representing approxim...
Alzchem Group AG: LIVIA Corporate Development SE and HDI Vier CE GmbH inform about intended private placement of in total up to 250.000 Alzchem Group AG shares
Trostberg, December 10, 2024 – LIVIA Corporate Development SE and HDI Vier CE GmbH have informed Alzchem Group AG (ISIN DE000A2YNT30, WKN A2YNT3, Prime Standard) today that they intend to s...
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, December 9th, 2024
1st Interim Report
In the period from December 2nd up to and including December 6th, 2024, a total of 2,337 shares of Alzchem Group AG were acquired as part of the share ...
Alzchem Group AG implements long-term succession planning for Management Board: Supervisory Board appoints Martina Spitzer as Chief Sales Officer effective January 1, 2025
Trostberg, December 4, 2024 – Alzchem Group AG, a globally active specialty chemicals company, is setting the course for continuous and sustainably successful development in Man...
Alzchem Group AG
Disclosure
according to Article 5 of the EU Regulation 596/2014
and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Share Repurchase
Alzchem Group AG announces the start of the share repurchase program which was published by an ad hoc announcement dated November 5, 2024.
Starting Dece...
EQS-Media / 12.11.2024 / 09:04 CET/CEST
Alzchem Group new partner of FC Bayern Basketball
Munich, November 12, 2024 – FC Bayern Basketball and Alzchem, a company based in Trostberg, have joined forces for the new season to achieve success together. With Alzchem's premium brand Creapure®, the internationally renowned manufacturer of creatine m...
Alzchem Group AG reports 36.4% EBITDA growth to EUR 76.8 million – strong earnings performance continues in the first nine months of 2024
Trostberg, November 7, 2024 – Alzchem Group AG, a globally active specialty chemicals company, continues its consistent transformation towards higher-margin specialty chemicals and was able to significantly incr...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .